Biotech Investment Analyst - Drug Asset & Company Assessment (Train AI Models Part Time!)

hackajob is collaborating with Mercor to connect them with exceptional professionals for this role.

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work - creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech analyst with a specialist-fund background for a paid pilot, with the potential to continue as the work scales.

Responsibilities
- Create and critique rubrics that analyze commercial drugs and drug-development programs
- Provide overall company and asset assessment

Requirements
Role
- Biotech analyst with a specialist-fund background

Also helpful
- Familiarity with biotech/pharma development programs

Engagement Details
- Duration: Approximately 10-20 hours over a 1-2 week paid pilot (analysis across roughly 5-10 companies); recurring for strong contributors
- Compensation: $125-$200/hour
- Location: Remote - US-based, or deep US-market experience (payer, formulary, and launch dynamics are US-specific); some overlap with US hours for occasional calls

Why Participate
- Help improve expert AI evaluation of drugs and drug-development programs
- Recurring engagement for strong contributors
- Flexible, remote participation
- Paid for your time and expertise